Greatbatch (GB) is a leading producer and supplier of batteries, capacitors and components used in implantable medical devices. The company has been acquiring several businesses over the last few years to revive top-line growth, which has been declining over the past few quarters.

Total revenues in the fourth quarter declined 14% year over year. The decline was broad-based across all sub-segments.

We continue to rate the stock an Underperform with a target price of $18. This is based on a P/E of 10.9x our fiscal 2010 EPS estimate.

Zacks Investment Research

1. (GB) Greatbatch Analyst Maintain Ratings at UnderperformWe recently reiterated our ‘Underperform’ rating on Greatbatch, Inc. (GB) with a target price of...
2. (GB) Greatbatch Receives FDA ApprovalGreatbatch Inc. (GB) recently received the U.S. Food and Drug Administration (FDA) 510 (k) approval...
3. (GB) Greatbatch’s Quarterly Report Beats ExpectationsGreatbatch, Inc. (GB) reported fourth quarter and fiscal 2009 results. The company’s fourth-quarter earnings per...
4. (GB) Greatbatch, Incorporated – Bear of the DayThe flurry of acquisition activities in the past few years have expanded Greatbatch‘s (GB) customer...
5. (GB) Greatbatch, Incorporated – Bear of the DayThe flurry of acquisition activities in the past few years have expanded Greatbatch‘s (GB) customer...
6. (GB) Greatbatch Inc’s Earnings Results DisappointGreatbatch, Inc. (GB) reported third quarter fiscal 2009 earnings per share of 32 cents, lower...

Search Posts by Tag: GB | Greatbatch Inc | Healthcare | Medical Appliances & Equipment

RSS Feeds by Tag: GB | Greatbatch Inc | Healthcare | Medical Appliances & Equipment |

Other Posts by: vitalstocks | RSS Feed for this author